SKP2 and breast cancer: In human BC MDA-MB-231 and SKBR3 cells, genistein exerted the same G2/M phase arrest in a dose-dependent manner and the molecular mechanism involved the inhibition of S-phase kinase-associated protein 2 (Skp2) and promotion of its downstream targets p21 and p27 [197].